Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in LYEL — Lyell Immunopharma, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$129,091
+$84,738 QoQ
Shares Held
9,188
+122.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 87 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. LYEL ranks #269 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in LYEL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $129,091 9,188
2025-03-31 $44,353 82,441
2024-12-31 $52,762 82,441
2024-09-30 $113,768 82,441
2024-06-30 $84,564 58,320
2024-03-31 $161,715 72,518
2023-12-31 $135,813 70,007
2023-09-30 $106,313 72,322
2023-06-30 $191,505 60,222
2023-03-31 $250,071 105,963
2022-12-31 $260,003 74,929
2022-09-30 $540,763 73,774
2022-06-30 $533,375 81,806
2022-03-31 $408,559 80,903
2021-12-31 $111,053 14,348
2021-09-30 $201,220 13,596